Protalix BioTherapeutics (PLX) FCF Margin (2009 - 2026)
Protalix BioTherapeutics' FCF Margin was -55.25% in Q2 2026, down 19.08 percentage points from -36.17% a year earlier and down 118.26 percentage points from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) FCF Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Protalix BioTherapeutics' FCF Margin was 9.51% through Jun 30, 2026, up 15.07 percentage points year-over-year; for FY2025, it was -25.84%, down 39.69 percentage points from FY2024.
- FCF Margin shows a five-year change of +16.70 percentage points (FY2020 to FY2025).
- In earlier years, FCF Margin was 13.84% in FY2024 (+17.61 pp), -3.77% in FY2023 (+50.03 pp), -53.80% in FY2022 (-23.17 pp) and -30.62% in FY2021 (+11.92 pp).
- The Q2 2026 figure marks the lowest quarterly FCF Margin since Q3 2023.
- Compared with a year earlier, FCF Margin was higher in two of the last eight quarters, with an average year-over-year change of -3.35 percentage points.
- The best year-over-year quarter for FCF Margin over five years was Q1 2024 (a gain of 129.64 percentage points); the worst was Q2 2022 (a drop of 182.51 percentage points).
- Per Business Quant data, PLX's FCF Margin in the three quarters before Q2 2026 was 63.00% (Q1 2026), 17.84% (Q4 2025) and -23.70% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 28.96% |
| 10 | Protalix BioTherapeutics | 230.43 Mn | 59.88 Mn | 14.05 Mn | 33.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 33.52% |
| Jun 30, 2026 | -55.25% |
| Mar 31, 2026 | 63.00% |
| Dec 31, 2025 | 17.84% |
| Sep 30, 2025 | -23.70% |
| Jun 30, 2025 | -36.17% |
| Mar 31, 2025 | -53.04% |
| Dec 31, 2024 | 19.57% |
| Sep 30, 2024 | 22.37% |
| Jun 30, 2024 | -28.07% |
| Mar 31, 2024 | 95.78% |
| Dec 31, 2023 | 31.90% |
| Sep 30, 2023 | -70.90% |
| Jun 30, 2023 | 13.60% |
| Mar 31, 2023 | -33.85% |
| Dec 31, 2022 | -32.77% |
| Sep 30, 2022 | -65.30% |
| Jun 30, 2022 | -85.50% |
| Mar 31, 2022 | -37.66% |
| Dec 31, 2021 | -64.74% |
API Access
Protalix BioTherapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();